CompletedPHASE2, PHASE3NCT02169882

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitas Padjadjaran
Principal Investigator
Rovina Ruslami, M.D., PhD
Faculty of Medicine Universitas Padjadjaran, Bandung, Indonesia
Intervention
Placebo(drug)
Enrollment
60 enrolled
Eligibility
15 years · All sexes
Timeline
2014 – 2017

Study locations (1)

Collaborators

United States Agency for International Development (USAID) · Radboud University Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02169882 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials